Related references
Note: Only part of the references are listed.Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
Guofeng Cheng
ADVANCED DRUG DELIVERY REVIEWS (2015)
MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
Ying-chun Gao et al.
TUMOR BIOLOGY (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
MiR-200, a new star miRNA in human cancer
Xiangling Feng et al.
CANCER LETTERS (2014)
The clinical and diagnostic role of microRNAs in ovarian carcinoma
Ben Davidson et al.
GYNECOLOGIC ONCOLOGY (2014)
The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer
Qingmin Sun et al.
GYNECOLOGIC ONCOLOGY (2014)
MicroRNAs: Novel Players in Cancer Diagnosis and Therapies
Aaron L. Oom et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Role of microRNAs in the Tumorigenesis of Ovarian Cancer
Gianpiero Di Leva et al.
FRONTIERS IN ONCOLOGY (2013)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition
Ausra Bendoraite et al.
GYNECOLOGIC ONCOLOGY (2010)
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
William C. S. Cho
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
Ram Eitan et al.
GYNECOLOGIC ONCOLOGY (2009)
Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries
Stacia K. Wyman et al.
PLOS ONE (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Patterns and progress in ovarian cancer over 14 years
John K. Chan et al.
OBSTETRICS AND GYNECOLOGY (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
